Search results for "Heart Diseases"

showing 10 items of 115 documents

Anderson-Fabry disease: clinical manifestations of disease in female heterozygotes.

2002

Anderson-Fabry disease is a rare, X-chromosomal lipid storage disorder caused by a deficiency of lysosomal alpha-galactosidase A. Clinical manifestations of Anderson-Fabry disease include excruciating pain in the extremities (acroparaesthesia), skin vessel ectasia (angiokeratoma), corneal and lenticular opacity, cardiovascular disease, stroke and renal failure, only renal failure being a frequent cause of death. Heterozygote female carriers have often been reported as being asymptomatic or having an attenuated form of the disease. To evaluate the spectrum of clinical signs in heterozygotes, a comprehensive clinical examination was performed on 20 carriers of Anderson-Fabry disease. This rev…

AdultMalePathologymedicine.medical_specialtyHeterozygoteX ChromosomeLipid storage disorderAdolescentHeart DiseasesGastrointestinal DiseasesPhysical examinationDiseaseAsymptomaticGlycosphingolipidsGeneticsmedicineHumansParesthesiaChildGenetics (clinical)Cause of deathmedicine.diagnostic_testVascular diseasebusiness.industrymedicine.diseaseFabry diseaseDermatologyAngiokeratomaCerebrovascular DisordersChild PreschoolBlood VesselsFabry DiseaseFemaleKidney Diseasesmedicine.symptombusinessJournal of inherited metabolic disease
researchProduct

Alteration of the growth hormone axis, visceral fat dysfunction, and early cardiometabolic risk in adults: the role of the visceral adiposity index

2015

The aim of the study is to clarify the relationship between adipose tissue dysfunction, metabolic profile and growth hormone (GH)/insulin-like growth factor (IGF)-I secretion in healthy adult subjects. We investigated the metabolic profile in a cohort of 231 consecutive healthy subjects in relation to GH, IGF-I levels, and visceral adiposity index (VAI). Anthropometric measures, lipid profile, and glucose and insulin levels during oral glucose tolerance test, Homa-IR and ISI Matsuda, IGF-I and GH peak after GHRH plus Arginine test were analyzed. The subjects with high VAI showed lower GH peak (22.8 ± 11.1 vs. 42.2 ± 21.3 µg/L; p = 0.049) and lower IGF-I (presented as IGF-I under normal rang…

AdultMaleRiskmedicine.medical_specialtyHeart Diseasesmedicine.medical_treatmentEndocrinology Diabetes and MetabolismAdipose tissueIntra-Abdominal FatBiologySettore MED/13 - EndocrinologiaCohort StudiesEndocrinologyMetabolic DiseasesInternal medicineDiabetes mellitusmedicineHealth Status IndicatorsHumansMetabolic riskInsulin-Like Growth Factor IProspective cohort studyGrowth hormoneSubclinical infectionGH deficiencymedicine.diagnostic_testHuman Growth HormoneInsulinGH deficiency; Growth hormone; Metabolic risk; Visceral adiposity; Endocrinology; Endocrinology Diabetes and MetabolismMiddle Agedmedicine.diseaseEndocrinologyBlood pressureCohortFemaleVisceral adiposityLipid profile
researchProduct

Clinical Perspective on Antihypertensive Drug Treatment in Adults With Grade 1 Hypertension and Low-to-Moderate Cardiovascular Risk:An International …

2017

Hypertension is a leading risk factor for disease burden globally. An unresolved question is whether grade 1 hypertension (140-159/90-99. mm. Hg) with low (cardiovascular mortality <1% at 10 years) to moderate (cardiovascular mortality ≥1% and <5% at 10 years) absolute total cardiovascular risk (CVR) should be treated with antihypertensive agents. A virtual international consultation process was undertaken to summarize the opinions of select experts. After holistic analysis of all epidemiological, clinical, psychosocial, and public health elements, this consultation process reached the following consensus in hypertensive adults aged <80 years: (1) The question of whether drug treat…

AdultMaleRiskmedicine.medical_specialtyPediatricsEvidence-based practiceHeart Diseasesmedicine.drug_classMEDLINE030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicineHypertension/complicationsEpidemiologymedicineHumans030212 general & internal medicineRisk factorAntihypertensive drugAntihypertensive AgentsDisease burdenAntihypertensive Agents/therapeutic usebusiness.industryPublic healthHeart Diseases/etiologyGeneral MedicineHypertensionFemaleCardiology and Cardiovascular MedicinebusinessPsychosocial
researchProduct

Pharmacological stress, rest perfusion and delayed enhancement cardiac magnetic resonance identifies very early cardiac involvement in systemic scler…

2017

Objective To evaluate occult cardiac involvement in asymptomatic systemic sclerosis (SSc) patients by pharmacological stress, rest perfusion and delayed enhancement cardiac magnetic resonance (CMR), for a very early identification of patients at higher risk of cardiac-related mortality. Methods Sixteen consecutive patients with definite SSc, fulfilling the American College of Rheumatology/European League Against Rheumatism 2013 classification criteria in less than 1 year from the onset of Raynaud's phenomenon, underwent pharmacological stress, rest perfusion and delayed enhancement CMR. At enrollment, no patient showed signs and/or symptoms suggestive for cardiac involvement. No patient sho…

AdultMalemedicine.medical_specialtyAdenosineHeart diseaseHeart DiseasesVasodilator AgentsContrast MediaMagnetic Resonance Imaging CineAsymptomaticCardiac magnetic resonance imaging with pharmacological stress; Myocardial perfusion defect; Systemic sclerosis; Systemic sclerosis heart involvement; Rheumatology030218 nuclear medicine & medical imaging03 medical and health sciencesMyocardial perfusion imagingCoronary circulation0302 clinical medicineRheumatologyPredictive Value of TestsInternal medicineCoronary CirculationCardiac magnetic resonance imaging with pharmacological stressMultidetector Computed TomographymedicineHumans030203 arthritis & rheumatologyScleroderma Systemicmedicine.diagnostic_testbusiness.industryMicrocirculationMyocardial Perfusion Imagingmedicine.diseaseRheumatologymyocardial perfusion defectSettore MED/16 - Reumatologiamedicine.anatomical_structureEarly DiagnosisVentriclecardiac magnetic resonance imaging with pharmacological streAsymptomatic Diseasessystemic sclerosis heart involvementSystemic sclerosisFemaleRadiologymedicine.symptombusinessPerfusionsystemic sclerosiRheumatism
researchProduct

Haemodynamic effects of a single intravenous dose of lorcainide in patients with heart disease

1980

The cardiovascular effects of a single i.v. dose (2 mg/kg over 5 min) of lorcainide were studied in 14 patients with heart disease. In the haemodynamic part of the study (6 patients), the aortic and pulmonary systolic, diastolic and mean pressures, left ventricular systolic and end-diastolic pressures, cardiac output and the rate of rise of left ventricular pressure were measured before and for 30 min after administration of the drug. Lorcainide produced a slight and short-lasting decrease in the aortic and pulmonary systolic pressures, and all other pressure values remained unchanged. The cardiac output and systemic vascular resistance were not altered by lorcainide. It consistently depres…

AdultMalemedicine.medical_specialtyCardiac outputTime FactorsHeart DiseasesHeart diseaseBenzeneacetamidesDiastoleHemodynamicsBlood PressureLorcainidePiperidinesInternal medicinemedicineHumansPharmacology (medical)Cardiac OutputAgedPharmacologyEjection fractionbusiness.industryHeartGeneral MedicineMiddle Agedmedicine.diseaseMyocardial Contractionmedicine.anatomical_structureAnesthesiaVascular resistanceVentricular pressureCardiologyFemaleVascular ResistancebusinessAnti-Arrhythmia Agentsmedicine.drugEuropean Journal of Clinical Pharmacology
researchProduct

Distribution and categorization of left ventricular measurements in the general population: results from the population-based Gutenberg Heart Study.

2010

Background— Echocardiography, the dominant imaging modality for quantification of left ventricular metrics, has undergone continuing development in the past few decades. However, given the lack of population-based data, current guidelines are still based on restricted and small data sets analyzed with methods including expert opinion. This work presents empirically derived reference values from a large-scale, epidemiologic study conducted with state-of-the-art imaging technology and methods. Methods and Results— The distribution of echocardiographic measurements of the left ventricle was analyzed in a population-based sample of 5000 mid-Europeans from the Gutenberg Heart Study in Germany. …

AdultMalemedicine.medical_specialtyHeart DiseasesHeart VentriclesPopulationSample (statistics)Severity of Illness IndexVentricular Function LeftAge DistributionSex FactorsPredictive Value of TestsReference ValuesGermanyMedicineHumansRadiology Nuclear Medicine and imagingProspective StudiesSex DistributioneducationAgedUltrasonographyAged 80 and overeducation.field_of_studybusiness.industryAge FactorsNomogramMiddle AgedHealth SurveysQuantile regressionSurgeryData setNomogramsCategorizationPredictive value of testsImaging technologyFemaleCardiology and Cardiovascular MedicinebusinessCartographyCirculation. Cardiovascular imaging
researchProduct

In-hospital complications of acute myocardial infarction in hypertensive subjects

2005

Recent studies have shown a worse in-hospital outcome in hypertensive than in normotensive patients with acute myocardial infarction (AMI), which has been attributed to more frequent complications. The aim of this study was to investigate clinical patterns, risk factors, and in-hospital complications in hypertensive and normotensive patients with AMI.Of 4994 consecutive patients with AMI admitted to the intensive care unit, hypertensive patients with first infarction (n = 915; mean age 68.8 +/- 11.4 years) and 915 gender- and age-matched normotensive subjects were retrospectively studied.In the univariate analysis, hypertensive subjects presented more frequently non-Q-wave infarction and ST…

AdultMalemedicine.medical_specialtyHeart DiseasesMyocardial InfarctionInfarctionlaw.inventionElectrocardiographylawInternal medicineDiabetes mellitusInternal MedicinemedicineHumansST segmentcardiovascular diseasesMyocardial infarctionAntihypertensive AgentsAgedRetrospective StudiesAged 80 and overST depressionInpatientsUnivariate analysisbusiness.industryCoronary Care UnitsMiddle Agedmedicine.diseaseIntensive care unitCase-Control StudiesHypertensionCardiologyFemalemedicine.symptombusinessDyslipidemiaAmerican Journal of Hypertension
researchProduct

Linear and nonlinear heart rate dynamics in elderly inpatients. Relations with comorbidity and depression

2010

Background. Hospitalization processes are known to increase depressive symptoms arising among elderly population. Meanwhile, dysregulation of cardiac autonomic function has been suggested to link depression and cardiovascular mortality. In this context, analysis of heart rate variability (HRV) is emerging as a powerful mortality risk stratifier clinical tool. The purpose of the study was to examine the relationship among HRV, depression, and comorbidity risk among an elderly inpatient population. Material and methods. Twenty-six subjects (aged 78±9 years) were recruited from the Short- Term Stay Unit at the Hospital General de Alicante. Before joining a Physical Activity Program aimed to pr…

AdultMalemedicine.medical_specialtyHeart DiseasesPopulationContext (language use)Risk AssessmentelderlySampling StudiesinpatientsElectrocardiographySex FactorsHeart RateInternal medicineHeart ratePrevalencemedicineAnimalsHumansHeart rate variabilityeducationGeriatric AssessmentDepression (differential diagnoses)AgedAged 80 and overeducation.field_of_studybusiness.industryAge Factorsheart rate variabilityGeneral Medicinemedicine.diseaseComorbiditySample entropycomorbidityNonlinear DynamicsData Interpretation StatisticaldepressionPhysical therapyheart rate variability; comorbidity; depression; elderly; inpatientsFemaleGeriatric Depression ScalebusinessMedicina
researchProduct

Left ventricular volume determination using Albunex.

1996

The aim of this study was to assess the ability of intravenous injection of Albunex to improve left ventricular volume determination in patients with various cardiac diseases. It is conceivable that the intravenous injection of microbubbles could improve echocardiographic left ventricular border delineation leading to improved interobserver variability. Echocardiograms were obtained during simultaneous intravenous injection of 0.08 and 0.12 ml/kg Albunex (four-chamber view). Within 6 hours after the recording of the contrast echocardiograms routine left heart angiography was performed. Volumes were measured using the slice method in native and contrast echocardiograms as well as in the angi…

AdultMalemedicine.medical_specialtyHeart DiseasesSystoleCardiac VolumeHeart angiographyContrast MediaEnd systoleVentricular Function LeftDiastoleInternal medicineAlbuminsmedicineConfidence IntervalsHumansRadiology Nuclear Medicine and imagingIn patientEnd diastoleAgedObserver VariationEjection fractionbusiness.industryCineradiographyAngiocardiographyHeartStroke VolumeMiddle AgedConfidence intervalMicrospheresEchocardiographyInjections IntravenousCardiologyMicrobubblesVentricular volumeFemaleCardiology and Cardiovascular MedicinebusinessJournal of the American Society of Echocardiography : official publication of the American Society of Echocardiography
researchProduct

Different patterns of myocardial iron distribution by whole-heart T2* magnetic resonance as risk markers for heart complications in thalassemia major.

2014

Background The multislice multiecho T2* cardiovascular magnetic resonance (CMR) technique allows to detect different patterns of myocardial iron overload (MIO). The aim of this cross-sectional study was to verify the association between cardiac complications (heart failure and arrhythmias), biventricular dysfunction and myocardial fibrosis with different patterns of MIO in thalassemia major (TM) patients. Methods We considered 812 TM patients enrolled in the Myocardial Iron Overload in Thalassemia (MIOT) Network. The T2* value in all the 16 cardiac segments was evaluated. Results We identified 4 groups of patients: 138 with homogeneous MIO (all segments with T2* < 20 ms), 97 with heterogene…

AdultMalemedicine.medical_specialtyHeart DiseasesThalassemiaIronMyocardial ironMagnetic Resonance Imaging CineMyocardial iron overloadYoung AdultRisk FactorsInternal medicineMedicineDistribution (pharmacology)HumansMultisliceChelation therapyCardiac complicationThalassemia majormedicine.diagnostic_testbusiness.industryMyocardiumbeta-ThalassemiaMagnetic resonance imagingmedicine.diseaseCross-Sectional StudiesHeart failureCardiologyMyocardial fibrosisCardiovascular magnetic resonanceFemaleCardiology and Cardiovascular MedicinebusinessInternational journal of cardiology
researchProduct